Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Metric	REGNRegeneron Pharmaceuticals	ARGXargenx SE	VRTXVertex Pharmaceuticals
Snapshot
Price	$776.43	$880.94	$488.82
Market cap	$68.59B	$55.53B	$115.02B
Valuation
P/E	18.4x	26x	28.7x
Forward P/E	17.6x	18.6x	27x
Growth
Revenue growth	5.9%	80.6%	10.1%
EPS growth	4.4%	111.4%	6.1%
Profitability
Net margin	29.6%	48.2%	35.5%
ROE	14.3%	22.9%	23.9%
Balance sheet & cash
Debt / equity	0.09x	0.01x	0.01x
Free cash flow yield	6.3%	—	3.1%
Dividend yield	0.6%	—	—
Verdict
Investment rating	Favorable· 69	Strong· 88	Favorable· 67

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

Year	REGNtoday $776	ARGXtoday $881	VRTXtoday $489
2027	$607.94 – $891.65+15% CAGR	$1,396.86 – $2,048.73+133% CAGR	$389.05 – $570.61+17% CAGR
2028	$634.69 – $930.88+9% CAGR	$2,953.25 – $4,331.43+122% CAGR	$412.86 – $605.53+11% CAGR
2029	$662.62 – $971.84+8% CAGR	$6,243.75 – $9,157.51+118% CAGR	$438.13 – $642.59+10% CAGR
2030	$691.78 – $1,014.60+7% CAGR	$13,200.55 – $19,360.80+117% CAGR	$464.94 – $681.92+9% CAGR
2031	$722.21 – $1,059.25+6% CAGR	$27,908.59 – $40,932.60+115% CAGR	$493.40 – $723.65+8% CAGR
5-yr CAGR	-1.4% – 6.4%	99.6% – 115.5%	0.2% – 8.2%